BMS-814580
BMS-814580 is an orally active, highly efficacious MCHR1 inhibitor with a Ki of 16.9 nM against hMCHR1. BMS-814580 shows antiobesity activities.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 1197420-11-3
- Formel: C24H19ClF2N2O4S
- Molecular Weight:504.93
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
Beschreibung
IC50 & Target
Ki: 16.9 nM (MCHR1)[1]
In Vitro
BMS-814580 (3.0 μM; 10 min) shows stability with 90%, 95% and 100% remaining in human, rat and mouse liver microsomes, respectively[1].
BMS-814580 displays modest in vitro ion channel inhibition of 43%, 21%, and 15%, respectively, for hERG, Na (4 Hz), and L-type Ca channels at 10 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. .
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Obese male SD rats, chronic diet-induced obese (DIO) rat model[1]
-
Dosage:0.03, 0.1, 0.3, 1 and 3 mg/kg
-
Administration:Orally administered as the phosphate prodrug, once daily for 28 days
-
Result:Dose dependently reduced body weight.
-
Animal Model:Sprague-Dawley Rats[1]
-
Dosage:10 mg/kg
-
Administration:Oral administration, once
-
Result:Pharmacokinetics (PK) and Pharmacodynamics (PD) Data: Plasma and Brain Concentrations of Cyclic Tertiary Alcohols and the Effect on Body Weights in Sprague-Dawley Rats
8 h rat PK studyb 4-day PD studyc day 4 parent compd concn at 20 h compd dosed asa AUC (μM•h) brain (nM) plasma (nM) % weight loss brain (nM) plasma (nM) BMS-814580 glycinate 38.1 11330 4500 6.4d 7955 12801
aRats were dosed orally with parent compound or a prodrug; prodrugs doses were adjusted to parent compounds. Vehicle = 0.5% Methocel, 0.1% Tween 80, 99.4% distilled water. bDose = 10 mg/kg; plasma and brain concentrations are reported 8 h after dose, n = 2. cCompounds were dosed at 3, 10, and 30 mg/kg orally once a day for 4 days; weight loss data is reported only for the 10 mg/kg dose, n = 8; reduction in body weight is reported as % change from baseline body weight compared to vehicle treated animals. NT = not tested. dNo biliary lesions were seen in this model.
-
Animal Model:Sprague-Dawley Rats[1]
-
Dosage:10 mg/kg (phosphate prodrug) or 1 mg/kg
-
Administration:Oral (phosphate prodrug) or intravenous administration (Pharmacokinetic Analysis)
-
Result:Pharmacokinetics Data for BMS-814580 in Rata
species compd (mg/kg) route of admin Cmax (μM) Tmax (h) AUC0−∞ (μM•h) T1/2 (h) CL (mL/min/kg) Vss(L/kg) F (%) rat BMS-814580 (1) iv 11.5 >24 0.9 4.1 BMS-814580 phosphate (10) po 4.0 6.7 107 54
aVehicles: iv, PEG400/DMAC/water (70:5:25); po, Methocel/Tween80/water (0.5:0.1:99.4).
Chemical Information
-
CAS. Nr. 1197420-11-3
-
Molecular Weight 504.93
-
Formel C24H19ClF2N2O4S
-
SMILES
O=C1C2=C(N=CN1C3=CC=C(OCC4(O)CC(C4)(F)F)C(OC)=C3)C=C(S2)C5=CC=C(C=C5)Cl
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
BMS-814580 Related Classifications
HY-120608 Related Classifications
Powered by Bioz